Z Zhang, Y Li, R Shi, C Jia, S Xu,
G Zhu, P Cao… - Cell Death & …, 2024 - nature.com
Osimertinib is a third-generation epidermal growth factor receptor (EGFR) tyrosine kinase
inhibitor (EGFR-TKI) approved for patients with EGFR T790M resistance mutations as first-or …